NCT01733290View on ClinicalTrials.gov

Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Dysfunctional Voiding
Interventions
DRUG

Botulinum toxin A

A total of 100 units of BoNT-A will be injected deeply into the external sphincter at the 3, 6, 9 and 12 o'clock positions in approximate equal aliquot.

DRUG

Normal saline instillation

Normal saline instillation

Trial Locations (1)

970

Buddhist Tzu Chi General Hospital, Hualien City

All Listed Sponsors
lead

Buddhist Tzu Chi General Hospital

OTHER

NCT01733290 - Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding | Biotech Hunter | Biotech Hunter